Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Dental Membranes and Bone Graft Substitutes Market – Breakthrough for Dental Bone Regeneration
Dental membranes and bone graft substitutes are used for dental bone regeneration procedures in patients affected by oral health disorders such as periodontal diseases and oral cancer. Dental membranes are used alongside dental bone grafts to allow cell proliferation during regeneration process. The increasing demand for dental implants for bone regeneration process is expected to offer lucrative growth opportunities for market players in the global dental membranes and bone graft substitutes market.
The global dental membranes and bone graft substitutes market size was valued at US$ 745.0 million in 2018 and is expected to exhibit a CAGR of 9.1% over the forecast period (2019–2027).
Figure 1. Global Dental Membranes and Bone Graft Substitutes Market Value (US$ Mn), By Region, 2018
Source: Coherent Market Insights Analysis (2020)
The increasing incidence of oral disorders such as periodontal diseases and oral cancer, high number of product launches, and rising adoption of expansion strategies by manufacturers are some of the major factors propelling growth of the global dental membranes and bone graft substitutes market
The increasing incidence of oral health disorders such as periodontal diseases and oral cancer is expected to drive the global dental membranes and bone graft substitutes market growth during the forecast period. For instance, according to the National Center for Biotechnology Information (NCBI) article published in 2015, Assessment of the Status of National Oral Health Policy in India states that prevalence of oral diseases is very high in India with dental caries. It reports that prevalence is 50.0%, 52.5%, 61.4%, 79.2%, and 84.7% in 5, 12, 15, 35-44, and 65-74 year old people, respectively.
Moreover, increasing product development and focus on addressing demand for efficient therapeutics by manufacturers are expected to drive growth of the market over the forecast period. For instance, according to the National Oral Health Survey of India, the prevalence of periodontal diseases was around 79.9% in individuals between the age of 65 and 74 years while the incidence of oral cancer in India was around 12.6 per 100,000 inhabitants during 2016- 2017.
However, stringent government regulations and high cost of bone graft procedures are expected to hinder growth of the global dental membranes and bone graft substitutes market during the forecast period. Certain government policies do not allow community healthcare facilities to expand their network in rural areas and thus, the companies are unable to expand and increase their sales. However, China has urban area focused policy for development. Due to this government policy, it does not allow community healthcare facilities to expand their network in rural areas and thus, the companies are unable to expand and increase their sales.
Figure 2. Global Dental Membranes and Bone Graft Substitutes Market Share (%), by Product Type, (2019 and 2027)
Source: Coherent Market Insights Analysis (2020)
The increasing patient population and collaboration and acquisition activities are expected to bolster the market growth
Europe is expected to hold dominant position in the global dental membranes and bone graft substitutes market over the forecast period due to increasing product approvals. For instance, in June 2018, Datum Dental received the CE Mark for a new biomaterial called Ossix Bone for bone regeneration after dental procedure in Europe. Ossix Bone is composed of collagen and hydroxyapatite. The biomaterial duplicates the natural glycation process in the formation of collagen bone, cartilage, skin, and blood vessels.
Major manufacturers are adopting growth strategies such as acquisition to increase product availability in newer geographies, which is expected to propel growth of the market during the forecast period. For instance, in 2017, Lifenet Health acquired Austria-based tissue bank, AlloTiss Gemeinnutzige Gewebebank GmbH. The acquisition helped Lifenet Health to expand its geographical footprint in Europe.
Key Players
Major players operating in the global dental membranes and bone graft substitutes market include Zimmer Biomet Holdings, Inc., Geistlich Pharma North America Inc., ACE Surgical Supply Company, Inc., BioHorizons, Inc., LifeNet Health, RTI Surgical Holdings, Inc., Institut Straumann AG, Dentsply Sirona Inc., and Citagenix, Inc.
US :
INDIA :
UK :
JAPAN :
U.S. :
+1-206-701-6702
UK :
+44-020-8133-4027
JAPAN :
+81-50-5539-1737
INDIA :
+91-848-285-0837
Sales Office (U.S.) : 
